Speakers

Expand/Collapse

Madiha Khurshid
Senior Associate Scientist
Amgen

Navin Tiwari
Head of Digital Shop Floor Automation
Sanofi

Day Two

Thursday January 30, 2020

4:30 pm | Contingency Planning Panel Discussion

Pre-Conference Focus Day

Tuesday January 28, 2020

2:30 pm | IT Infrastructure Required to Support an Automated ‘Industry 4.0’ Facility

Moiz Diwan
Director, Head of Enabling Technology Group
AbbVie

Day One

Wednesday 29th January 2020

9:45 am | Panel Discussion: Where’s the Real Barrier to CM Implementation; Regulatory, Strategic or Economic?

Jeroen Geens
Scientific Director, Drug Product Development
Janssen R&D

Andrew Falconbridge
Vice President Process Technology & Innovation
Alvotech

Flavien Susanne
Head of Chemical Development and Engineering
Sanofi

Day One

Wednesday 29th January 2020

9:45 am | Panel Discussion: Where’s the Real Barrier to CM Implementation; Regulatory, Strategic or Economic?

Richard Ding
Director, Downstream Process Development Manufacturing
AnaptysBio

Adam Clarke
Process Engineer
AstraZeneca

Day Two

Thursday January 30, 2020

10:00 am | Application of Continuous Processing to Go Green & Meet Sustainability Goals

Pre-Conference Focus Day

Tuesday January 28, 2020

11:15 am | Capability Building for Continuous Manufacturing & Scale up

Ronald Maurer
Principal Scientist, Downstream Process Development
Bristol-Myers Squibb

Day One

Wednesday 29th January 2020

9:45 am | Panel Discussion: Where’s the Real Barrier to CM Implementation; Regulatory, Strategic or Economic?

Nick Thomson
Senior Director, Chemical Research & Development
Pfizer Inc.

Nick graduated from the University of Edinburgh with a BSc (Hons) in Environmental Chemistry before completing a PhD in organic synthesis under Prof. Gerry Pattenden at the University of Nottingham.   Nick worked briefly at Zeneca Fine Chemicals Manufacturing Organization, Grangemouth (UK) and joined Pfizer in 1997 as a synthetic chemist in Process Research & Development.  Nick spent his early Pfizer career in the evolving process chemistry departments in Sandwich (UK), Sittingbourne (UK) and Holland, Michigan (USA).  From 2005 to 2010, Nick led the Sandwich Research Active Pharmaceutical Ingredient (API) department, with accountability for delivery of API technology from lead development to proof of concept.  In 2011, Nick joined the Pfizer Chemical Research and Development department in Groton, Connecticut (USA), as a Director of API Process Chemistry Laboratories, with accountability for the Quality by Design development and submission of late stage candidates.  In 2014, Nick became head of the Technology API line for Pfizer Chemical Research and Development, with accountability for Technology Strategy, High Throughput Screening, Biocatalysis and Flexible API Supply Technologies (Continuous).  Nick has been active in cross pharmaceutical precompetitive collaboration, as Chair of the IQ API Leadership Team and a board member of the Enabling Technologies Consortium.

Day Two

Thursday January 30, 2020

9:30 am | Exploiting Modularization for Flexible Manufacturing & to Drive Down Environmental & Facility Footprint

Tiago Vieira
Principal Scientist
Gilead Sciences

Day Two

Thursday January 30, 2020

4:30 pm | Contingency Planning Panel Discussion

Letha Chemmalil
Principal Scientist
Bristol-Myers Squibb

Oliver Thiel
Executive Director Process Development
Amgen

Matthew Beaver
Senior Scientist – Process Development
Amgen

Jon Coffman
Senior Director of Bioprocess Technologies
AstraZeneca

Dejan Arzense
Principal Scientist
Novartis

Pre-Conference Focus Day

Tuesday January 28, 2020

10:45 am | Group Exercise: Facility Design for the Implementation of Continuous Processing

Celia Cruz
Senior Director
Eli Lilly

Christos Varsakelis
Senior Manager Global Data Analytics & Innovation, R&D
GSK

Day One

Wednesday 29th January 2020

4:00 pm | A Holistic Approach to the Industry 4.0 Investment Agenda: Breaking Down the Fences Between R&D & Manufacturing

Ruth Hardy
Team Leader
Pfizer

Sarah Pope Miksinski
Senior Director, Global Regulatory Affairs
AstraZeneca

Day One

Wednesday 29th January 2020

9:15 am | Integration Regulatory Teams in Industry CM Process Development

Jean-Marc Bielser
Associate Manager. Technology & Innovation
Merck Group

Sean Daughtry
Director Technical Operations
Vertex

Day Two

Thursday January 30, 2020

4:30 pm | Contingency Planning Panel Discussion

4:00 pm | Tech Transfer Troubleshooting & CMO Collaboration

Nima Yazdanpanah
Advanced Manufacturing Consultant
Procegence

Pre-Conference Focus Day

Tuesday January 28, 2020

12:30 pm | Modeling & Simulations for Continuous Manufacturing Applications

Rob Bowen
Director
Facilities Integration Ltd.

Pre-Conference Focus Day

Tuesday January 28, 2020

10:45 am | Group Exercise: Facility Design for the Implementation of Continuous Processing

10:00 am | Continuous Processing; A Process Architect’s View

Lisa Graham
VP, Analytics Engineering
Seeq Corporation

Dr. Lisa Graham leads the Analytics Engineering team at Seeq Corporation. She holds her Ph.D. in chemical engineering and is a registered professional chemical engineer. With 20 years of experience across many industries, including pharmaceuticals and life sciences, and specialty chemicals, Lisa’s technical strengths include chemical engineering, product development, and process model development. She has a well-developed acumen in crafting process analytical technology and data analytics solutions to help drive innovation and growth, while reducing costs. Lisa has a strong business background established through C-Level leadership positions, including COO and SVP roles at Bend Research (now Lonza), and founding Alkemy Innovation in Bend, Oregon. She is actively involved in supporting higher education and specific STEM education initiatives. Specific efforts include serving as Director on the Oregon Governor's STEM Investment Council and as Chair of the Oregon Board of Trustees for Oregon Tech University.

Day One

Wednesday 29th January 2020

9:45 am | Panel Discussion: Where’s the Real Barrier to CM Implementation; Regulatory, Strategic or Economic?

Hans Johansson
Global Applications Director, Life Sciences
Purolite

Hans J Johansson is Global Applications Director at Purolite Life Sciences, Llantrisant, Wales. He has spent more than 30 years in the Biotech industry. Most of the time in research and development at Pharmacia/Amersham/GE Healthcare with a special focus on design and applications of industrial chromatography resins intended for antibody purification. He frequently publishes in scientific journals and is the holder of more than ten patents around resin design and large-scale protein purification. He is currently working with development and applications of novel, agarose-based, chromatography resins.

Bob Lenich
Director, Life Sciences Business
Emerson

Bob is a life-long learner who stays engaged in new technology and organizational trends in order to adapt them to solving operating issues across the process industries. He works with a wide variety of organizations to identify operational problems, evaluate how to make improvements, and then justify and sell the approach. Bob loves seeing the successful deployment of a solution and then sharing the benefits so that others can take advantage of the approach. Bob gets special gratification from seeing how those improvements help areas like Life Science manufacturing improve people’s lives. Bob currently is responsible for planning Emerson's strategy for growing our automation business in the Life Science industry globally.  He then collaboratively works across the various business units in Emerson to implement the strategy and build the business. Bob has a BS in Chemical Engineering from Rose Hulman Institute of Technology and an MBA from the University of Texas.

Senior Representative

DFE Pharma

Gerard Gach
Chief Marketing Officer
YMC PROCESS TECHNOLOGIES, INC.

Gerard Gach is the Chief Marketing Officer (CMO) of YMC Process Technologies bio/pharma systems’ business globally. His present role is identifying new growth segments within the life science space, providing strategic direction and aligning industry collaborators and developing product value insights. Previously Gerard spent 12+ years with General Electric as Global New Products Manager. He was the Global Strategic Leader, Bioprocess Cell Culture of General Electric’s Health Care (GEHC) Life Science Division. At GEHC Gerard also served as Director of Product Management for Bioreactors, Disposables, and Membrane business where his team was responsible for developing and bringing to market an entirely new platform over 250 single use products while managing membrane based products for the GE business involved in bioprocess, protein science and lab products. He has previously served as Global Marketing Leader, for the Advanced Separations business of GE Water & Process centered on novel membrane and chemical separation technology. His employment history includes over 30 years in the filtration / separations industry with GE, Osmonics, Koch Membrane Systems and Pall Corporation in capacities of R&D Supervisor, Sales and Sale Management, Strategy Development and Business Development. Gerard has a BS from St. John’s University with a focus in Chemistry and further course studies in Marketing, Business Law and Business Management. Gerard was the 2012 GE Corporate Life Time Community Service Award winner.

Senior Representative

Secoya

Gabriella Dahlgren
Senior Manager, PQM
Janseen

Day One

Wednesday 29th January 2020

9:45 am | Panel Discussion: Where’s the Real Barrier to CM Implementation; Regulatory, Strategic or Economic?